These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14981799)

  • 21. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin.
    He W; Jiang X; Zhang ZR
    J Pharm Sci; 2008 Jun; 97(6):2250-9. PubMed ID: 17853430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application.
    Supersaxo A; Hein W; Gallati H; Steffen H
    Pharm Res; 1988 Aug; 5(8):472-6. PubMed ID: 3244653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys.
    Ajariyakhajorn C; Mammen MP; Endy TP; Gettayacamin M; Nisalak A; Nimmannitya S; Libraty DH
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4508-14. PubMed ID: 16251289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems.
    Gao S; Xu Y; Asghar S; Chen M; Zou L; Eltayeb S; Huo M; Ping Q; Xiao Y
    J Drug Target; 2015; 23(6):481-96. PubMed ID: 25738991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumor.
    Gao H; Wang JY; Shen XZ; Deng YH; Zhang W
    World J Gastroenterol; 2004 Jul; 10(14):2010-3. PubMed ID: 15237424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to sequential treatment with lymphoblastoid interferon-alpha in patients with Ph+ chronic myeloid leukemia unresponsive to recombinant interferon-alpha (rIFN alpha 2a) and neutralizing-rIFN alpha 2a antibodies negative.
    Russo D; Candoni A; Grattoni R; Minisini R; Rosti G
    Haematologica; 1997; 82(3):348-50. PubMed ID: 9234589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo.
    Zhang L; Hou Y; Li C; Liu H; Wang Y
    Arab J Gastroenterol; 2022 Nov; 23(4):263-269. PubMed ID: 35922259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polybutylcyanoacrylate nanoparticles as novel vectors in cancer gene therapy.
    Zhang Y; Zhang Y; Chen J; Zhang B; Pan Y; Ren L; Zhao J; Luo Y; Zhai D; Wang S; Wang J
    Nanomedicine; 2007 Jun; 3(2):144-53. PubMed ID: 17468053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
    Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
    J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel method to prepare highly encapsulated interferon-alpha-2b containing liposomes for intramuscular sustained release.
    Yang L; Yang W; Bi D; Zeng Q
    Eur J Pharm Biopharm; 2006 Aug; 64(1):9-15. PubMed ID: 16797953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Investigation of drug release in vitro from mitoxantrone-nanospheres].
    Zhang Z; Liao G; Qian W
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Dec; 25(4):384-7. PubMed ID: 7744378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective decrease in Leu8-negative T cell subpopulations following treatment with recombinant interferon-alpha 2a (rIFN-alpha 2a).
    Martínez-Maza O; Figlin RA; Giorgi JV; Fahey JL
    Cell Immunol; 1988 Nov; 117(1):89-98. PubMed ID: 2902935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The pharmacokinetic study on cytarabine nanoparticle lyophilization injection in rabbits].
    Zhou J; Jiang XH; He L; Li CR; Yang JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):145-7. PubMed ID: 16468665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adamantiades-Behçet disease. Therapeutic administration of systemic recombinant interferon-alpha-2a].
    Zouboulis CC; Treudler R; Orfanos CE
    Hautarzt; 1993 Jul; 44(7):440-5. PubMed ID: 8365878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity.
    Olivier JC; Fenart L; Chauvet R; Pariat C; Cecchelli R; Couet W
    Pharm Res; 1999 Dec; 16(12):1836-42. PubMed ID: 10644071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The in vitro release kinetics of Daunorubicin polybutylcyanoacrylate nanoparticles].
    Peng Y; Liao G; Zhang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):168-70, 184. PubMed ID: 12212049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and lyophilization of itraconazole loaded poly(butylcyanoacrylate) nanospheres as a drug delivery system.
    Ćurić A; Keller BL; Reul R; Möschwitzer J; Fricker G
    Eur J Pharm Sci; 2015 Oct; 78():121-31. PubMed ID: 26171880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of acyclovir-polybutylcyanoacrylate-nanoparticles by emulsion polymerization method].
    Zhang Z; Tian H; He Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):329-33. PubMed ID: 10684106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoacrylate nanoparticles.
    Zhang ZR; He Q
    World J Gastroenterol; 1999 Aug; 5(4):330-333. PubMed ID: 11819460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.